EQL Pharma AB Logo

EQL Pharma AB

Develops and sells niche generic and specialty medicines, primarily in Nordic markets.

EQL | ST

Overview

Corporate Details

ISIN(s):
SE0005497732
LEI:
549300Q8B2D2AE8GCW21
Country:
Sweden
Address:
Stortorget 1, 222 23 Lund

Description

EQL Pharma AB is a pharmaceutical company that develops, markets, and sells generic and specialty medicines. The company's strategy centers on identifying and developing "niche generics," which are medically equivalent to originator drugs but face limited competition after patent expiration. Its business operations also include specialty pharmaceuticals and the parallel import of medicines. EQL Pharma emphasizes cost-efficiency and collaborates with a global network of development partners. The company serves pharmacies and hospitals, primarily in the Nordic markets, maintaining a portfolio of marketed products while cultivating an extensive pipeline of new medicines.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-18 11:00
Valberedningens förslag inför årsstämman i EQL Pharma AB
Swedish 322.2 KB
2025-08-18 11:00
The Nomination Committee’s proposal for the annual general meeting in EQL Pharm…
English 321.4 KB
2025-08-08 07:00 Swedish 1.2 MB
2025-08-08 07:00 English 1.3 MB
2025-07-25 08:00 Swedish 19.5 MB
2025-07-22 10:00
Kallelse till årsstämma i EQL Pharma AB
Swedish 281.5 KB
2025-07-22 10:00
Notice of annual general meeting in EQL Pharma AB
English 287.5 KB
2025-05-08 07:00 Swedish 1.3 MB
2025-05-08 07:00 English 1.3 MB
2025-03-07 08:30
New financial targets for the period 2024/25 – 2028/29
English 351.6 KB
2025-03-07 08:30
Nya finansiella mål för perioden 2024/25 - 2028/29
Swedish 291.7 KB
2025-02-24 09:24
Valberedning inför årsstämman 2025
Swedish 352.0 KB
2025-02-24 09:24
Nomination committee for the 2025 Annual General Meeting
English 216.8 KB
2025-02-05 07:00 Swedish 1.3 MB
2025-02-05 07:00 English 1.3 MB

Automate Your Workflow. Get a real-time feed of all EQL Pharma AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for EQL Pharma AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for EQL Pharma AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-02-17 christer fåhraeus Other Sell 100,000 8,620,000.00 SEK

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.